Alpine Associates Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Alpine Associates Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-975,900	Closed	-$35.1M	–	56
2022 Q4	$35.1M	Buy	+975,900	New	+$24.4M	1.6%	24

Alpine Associates Management's IMGO Position: Q1 2023 in Review

Alpine Associates Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 975,900 shares — an estimated $35.1M sold.

Alpine Associates Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $35.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Alpine Associates Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Alpine Associates Management sold 975,900 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $35.1M.
Alpine Associates Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Alpine Associates Management's Imago BioSciences, Inc. Common stock position peaked at $35.1M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Alpine Associates Management's 13F filing for Q1 2023, filed 10 May 2023.